Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vitality Biopharma Inc. (STVFD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,500
  • Shares Outstanding, K 7,910
  • Annual Sales, $ 250 K
  • Annual Income, $ -140 K
  • 60-Month Beta 2.66
  • Price/Sales 27.07
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4800 +33.33%
on 07/18/16
2.2500 -71.56%
on 07/21/16
+0.1300 (+25.49%)
since 07/15/16
3-Month
0.4800 +33.33%
on 07/18/16
2.2500 -71.56%
on 07/21/16
-0.0900 (-12.33%)
since 05/13/16
52-Week
0.3000 +113.33%
on 02/03/16
2.2500 -71.56%
on 07/21/16
-0.6900 (-51.88%)
since 08/14/15

Most Recent Stories

More News
Vitality Biopharma to Present at the 11th Annual LD Micro Main Event

Vitality Biopharma, Inc. (Ticker: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the...

STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination

-- Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board

STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
Sales of Medical and Recreational Cannabis are on the Rise

According to a report published by Hexa Research, the U.S. medical cannabis market size was valued at USD $5.44 Billion in 2016 and is anticipated to reach USD $19.48 billion by 2024. The industry is likely...

CANN : 1.9100 (+6.11%)
HLIX : 2.3100 (+3.59%)
AXIM : 1.7900 (+34.59%)
STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
TRTC : 0.9679 (-2.43%)
Vitality Biopharma Discovers and Patents Use of Cannabinoids for C.diff-Associated Diarrhea and Colitis

- Vitality's GI-targeted VBX-100 THC compound to be investigated as treatment of recurrent C. difficile infections

STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
Cannabis Sales are Projected to Rise Globally

According to data provided by European investment bank, Bryan, Garnier & Co., the legal global cannabis market is poised for growth of more than 1,000% over the next decade and could reach $140 billion...

CNAB : 0.3900 (-1.02%)
AXIM : 1.7900 (+34.59%)
HHPHF : 0.3200 (+5.26%)
NXTTF : 0.5613 (-2.79%)
STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
HC.CN : 0.415 (+1.22%)
CNABE : 0.3603 (-6.32%)
Medical Benefits in Legal Cannabis Continues to Garner More Attention

According to data published by Hexa Research, the U.S. medical cannabis market size was valued at USD $5.44 Billion in 2016 and is expected to hit USD $19.48 billion by 2024. The industry is projected...

CNAB : 0.3900 (-1.02%)
CVSI : 5.0100 (+6.37%)
LBUY : 1.2275 (-1.80%)
STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
CNABE : 0.3603 (-6.32%)
SGMD : 0.0450 (+0.22%)
The Legal Cannabis Market Continues to Show Growth Opportunities

According to data provided by European investment bank Bryan, Garnier & Co. the legal global cannabis market is poised for growth of more than 1,000% over the next decade and could reach $140 billion dollars...

SNIPF : 0.0477 (-11.01%)
CNAB : 0.3900 (-1.02%)
SRNA : 0.0645 (-6.39%)
SPN.VN : 0.065 (-7.14%)
NXTTF : 0.5613 (-2.79%)
STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
CNABE : 0.3603 (-6.32%)
Vitality Biopharma Launches Canadian Subsidiary Focused on Cannabinoid Genetics R&D

-Wholly-owned subsidiary to enable access to best available cannabinoid compounds in a federally-compliant manner and facilitate key collaborative research programs

STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)
Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide

-- THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity

STVFD : 0.6400 (+4.92%)
VBIO : 0.4000 (-11.11%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade STVFD with:

Key Turning Points

2nd Resistance Point 0.7599
1st Resistance Point 0.6999
Last Price 0.6400
1st Support Level 0.6100
2nd Support Level 0.5801

See More

52-Week High 2.2500
Fibonacci 61.8% 1.5051
Fibonacci 50% 1.2750
Fibonacci 38.2% 1.0449
Last Price 0.6400
52-Week Low 0.3000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar